Citation Impact

37 standout
Sub-graph 1 of 19

Citing Papers

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
2024 Standout
3 intermediate papers

Works of Chintan Dave being referenced

35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy
2020
Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among Men
2019

Author Peers

Author CCM CCICM GG EE Last Decade Papers Cites
Chintan Dave 80 119 90 129 44 510
Fangfang Guo 4 1 20 300
Conrado Furtado Albuquerque Cavalcanti 2 5 339
Kaushiki Mazumdar 8 3 1 2 34 886
Abhishek Aich 11 1 12 291
N. Sangeetha 1 1 11 598

All Works

Loading papers...

Rankless by CCL
2026